Matches in SemOpenAlex for { <https://semopenalex.org/work/W2807585481> ?p ?o ?g. }
- W2807585481 endingPage "5718" @default.
- W2807585481 startingPage "5704" @default.
- W2807585481 abstract "The optimization of a new class of small molecule PCSK9 mRNA translation inhibitors is described. The potency, physicochemical properties, and off-target pharmacology associated with the hit compound (1) were improved by changes to two regions of the molecule. The last step in the synthesis of the congested amide center was enabled by three different routes. Subtle structural changes yielded significant changes in pharmacology and off-target margins. These efforts led to the identification of 7l and 7n with overall profiles suitable for in vivo evaluation. In a 14-day toxicology study, 7l demonstrated an improved safety profile vs lead 7f. We hypothesize that the improved safety profile is related to diminished binding of 7l to nontranslating ribosomes and an apparent improvement in transcript selectivity due to the lower strength of 7l stalling of off-target proteins." @default.
- W2807585481 created "2018-06-13" @default.
- W2807585481 creator A5004987244 @default.
- W2807585481 creator A5005793698 @default.
- W2807585481 creator A5023487227 @default.
- W2807585481 creator A5024720734 @default.
- W2807585481 creator A5026541170 @default.
- W2807585481 creator A5029163369 @default.
- W2807585481 creator A5031672882 @default.
- W2807585481 creator A5033210199 @default.
- W2807585481 creator A5039778021 @default.
- W2807585481 creator A5040429139 @default.
- W2807585481 creator A5044709500 @default.
- W2807585481 creator A5044929765 @default.
- W2807585481 creator A5047941278 @default.
- W2807585481 creator A5052897370 @default.
- W2807585481 creator A5053370712 @default.
- W2807585481 creator A5054218209 @default.
- W2807585481 creator A5072802372 @default.
- W2807585481 creator A5077177263 @default.
- W2807585481 creator A5078570045 @default.
- W2807585481 creator A5078819292 @default.
- W2807585481 creator A5084732640 @default.
- W2807585481 date "2018-06-07" @default.
- W2807585481 modified "2023-09-24" @default.
- W2807585481 title "Small Molecule Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Hit to Lead Optimization of Systemic Agents" @default.
- W2807585481 cites W1968533519 @default.
- W2807585481 cites W1983029570 @default.
- W2807585481 cites W1983889140 @default.
- W2807585481 cites W1988137261 @default.
- W2807585481 cites W1990187433 @default.
- W2807585481 cites W2001313012 @default.
- W2807585481 cites W2001314633 @default.
- W2807585481 cites W2006492573 @default.
- W2807585481 cites W2018441811 @default.
- W2807585481 cites W2038841613 @default.
- W2807585481 cites W2045315353 @default.
- W2807585481 cites W2052700242 @default.
- W2807585481 cites W2055571770 @default.
- W2807585481 cites W2059940060 @default.
- W2807585481 cites W2063780360 @default.
- W2807585481 cites W2067539811 @default.
- W2807585481 cites W2070588466 @default.
- W2807585481 cites W2071154679 @default.
- W2807585481 cites W2073465333 @default.
- W2807585481 cites W2076431356 @default.
- W2807585481 cites W2076695593 @default.
- W2807585481 cites W2094222285 @default.
- W2807585481 cites W2143252778 @default.
- W2807585481 cites W2146660254 @default.
- W2807585481 cites W2148858610 @default.
- W2807585481 cites W2530737230 @default.
- W2807585481 cites W2601524907 @default.
- W2807585481 cites W2750222245 @default.
- W2807585481 cites W2765514511 @default.
- W2807585481 cites W2786967171 @default.
- W2807585481 cites W2793825078 @default.
- W2807585481 cites W2949885329 @default.
- W2807585481 cites W2951696419 @default.
- W2807585481 cites W4235942579 @default.
- W2807585481 cites W569183658 @default.
- W2807585481 doi "https://doi.org/10.1021/acs.jmedchem.8b00650" @default.
- W2807585481 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29878763" @default.
- W2807585481 hasPublicationYear "2018" @default.
- W2807585481 type Work @default.
- W2807585481 sameAs 2807585481 @default.
- W2807585481 citedByCount "34" @default.
- W2807585481 countsByYear W28075854812018 @default.
- W2807585481 countsByYear W28075854812019 @default.
- W2807585481 countsByYear W28075854812020 @default.
- W2807585481 countsByYear W28075854812021 @default.
- W2807585481 countsByYear W28075854812022 @default.
- W2807585481 countsByYear W28075854812023 @default.
- W2807585481 crossrefType "journal-article" @default.
- W2807585481 hasAuthorship W2807585481A5004987244 @default.
- W2807585481 hasAuthorship W2807585481A5005793698 @default.
- W2807585481 hasAuthorship W2807585481A5023487227 @default.
- W2807585481 hasAuthorship W2807585481A5024720734 @default.
- W2807585481 hasAuthorship W2807585481A5026541170 @default.
- W2807585481 hasAuthorship W2807585481A5029163369 @default.
- W2807585481 hasAuthorship W2807585481A5031672882 @default.
- W2807585481 hasAuthorship W2807585481A5033210199 @default.
- W2807585481 hasAuthorship W2807585481A5039778021 @default.
- W2807585481 hasAuthorship W2807585481A5040429139 @default.
- W2807585481 hasAuthorship W2807585481A5044709500 @default.
- W2807585481 hasAuthorship W2807585481A5044929765 @default.
- W2807585481 hasAuthorship W2807585481A5047941278 @default.
- W2807585481 hasAuthorship W2807585481A5052897370 @default.
- W2807585481 hasAuthorship W2807585481A5053370712 @default.
- W2807585481 hasAuthorship W2807585481A5054218209 @default.
- W2807585481 hasAuthorship W2807585481A5072802372 @default.
- W2807585481 hasAuthorship W2807585481A5077177263 @default.
- W2807585481 hasAuthorship W2807585481A5078570045 @default.
- W2807585481 hasAuthorship W2807585481A5078819292 @default.
- W2807585481 hasAuthorship W2807585481A5084732640 @default.
- W2807585481 hasConcept C161624437 @default.
- W2807585481 hasConcept C181199279 @default.
- W2807585481 hasConcept C185592680 @default.